Dr. Klarissa D. Jackson is an Assistant Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the University of North Carolina (UNC) at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA. She received her B.S. in chemistry from Jackson State University and her Ph.D. in pharmacology from Vanderbilt University. She completed a postdoctoral fellowship at the University of Washington School of Pharmacy in the Department of Medicinal Chemistry under the mentorship of Drs. Allan Rettie and Sidney Nelson. She joined the UNC Eshelman School of Pharmacy in 2019. Before joining UNC, she was an Assistant Professor at Lipscomb University College of Pharmacy in the Department of Pharmaceutical Sciences and an adjunct Assistant Professor at Vanderbilt University in the Department of Pharmacology. Her research interests focus on drug metabolism and toxicology to better understand the mechanisms of and risk factors for serious adverse drug reactions. Her research program has been supported by funding from the NIH National Cancer Institute Center to Reduce Cancer Health Disparities, the National Institute of General Medical Sciences, and the American Association of Colleges of Pharmacy. Her laboratory is currently investigating the roles of cytochromes P450 and non-P450 enzymes in the metabolism and hepatotoxicity of drugs that are used in various therapeutic areas.
Dr. Klarissa D. Jackson is an Assistant Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the University of North Carolina (UNC) at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, USA. She received her B.S. in chemistry from Jackson State University and her Ph.D. in pharmacology from Vanderbilt University. She completed a postdoctoral fellowship at the University of Washington School of Pharmacy in the Department of Medicinal Chemistry under the mentorship of Drs. Allan Rettie and Sidney Nelson. She joined the UNC Eshelman School of Pharmacy in 2019. Before joining UNC, she was an Assistant Professor at Lipscomb University College of Pharmacy in the Department of Pharmaceutical Sciences and an adjunct Assistant Professor at Vanderbilt University in the Department of Pharmacology. Her research interests focus on drug metabolism and toxicology to better understand the mechanisms of and risk factors for serious adverse drug reactions. Her research program has been supported by funding from the NIH National Cancer Institute Center to Reduce Cancer Health Disparities, the National Institute of General Medical Sciences, and the American Association of Colleges of Pharmacy. Her laboratory is currently investigating the roles of cytochromes P450 and non-P450 enzymes in the metabolism and hepatotoxicity of drugs that are used in various therapeutic areas.